[Cys26]-beta-amyloid (17-40), S26C beta-amyloid (17-40)

[Cys26]-beta-amyloid (17-40) adds a cysteine that promotes thiol-mediated modulation of peptide architecture. Alteration at residue 26 influences β-strand alignment and assembly behavior. The fragment is applied in studies on intermediate-state formation and solvent-driven folding. Its reactivity enables exploration of crosslinking patterns and aggregation interfaces.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: A13161

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.W/Mr.
2408.9
Sequence
LVFFAEDVGCNKGAIIGLMVGGVV
Length
24

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOcGMP Peptide ServicePeptide Modification ServicesCustom Conjugation ServicePeptide Synthesis ServicesPeptide Analysis ServicesPeptide Nucleic Acids SynthesisEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers